TPTX stock forecast
Our latest prediction for Turning Point Therapeutics, Inc.'s stock price was made on the Sept. 10, 2019 when the stock price was at 42.94$.
In the short term (2weeks), TPTX's stock price should outperform the market by 3.90%. During that period the price should oscillate between -8.81% and +13.20%.
In the medium term (3months), TPTX's stock price should outperform the market by 2.83%. During that period the price should oscillate between -17.73% and +31.10%.Get email alerts
About Turning Point Therapeutics, Inc.
Turning Point Therapeutics, Inc. engages in the discovery and development of precision medicines for cancer and other diseases. It focuses on the design of novel chemical identities for established oncogene drivers with secondary resistant mutations, newly identified disease-driven targets, and potential targets regulating tumor microenvironment and tumor immunity. The company was founded by J. Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -1.68$ per share.
The book value per share is 7.91$
Three months stock forecastSept. 10, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|